Medicare Payment Increase in Final Budget Reconciliation Bill
The bill includes a 2.5% increase to the Medicare Physician Fee Schedule for calendar year 2026.
Read moreMain Content
Bipartisan "Cures 2.1" White Paper Released in Waning Days of Last Congress
Jan. 10, 2025
U.S. Rep. Diana DeGette (D-CO) and former Rep. Larry Buchson (R-IN) released a 21st Century Cures 2.1 white paper Dec. 24, containing recommendations for consideration in the 119th Congress. The American College of Radiology® (ACR®) provided comments informing the document last summer.
The 21st Century Cures Act (2016) addressed topics related to software oversight, data sharing, biomedical research funding and payment policy. Congress began to examine Cures Act-related gaps and opportunities in 2019, an effort that was coined “Cures 2.0,” and ultimately helped establish the Advanced Research Projects Agency for Health (ARPA-H).
The latest white paper, “A Roadmap for 21st Century Cures Next Steps for the Cures 2.0 Act and the 21st Century Cures Initiative,” suggests focus areas for future Cures-related legislative activities, including changes to Medicare payment policy and local coverage determination processes, U.S. Preventive Services Task Force processes, clinical trials access, health information exchange, software/medical device oversight, and more.
ACR members with questions about Cures 2.0 can contact Michael Peters, ACR Senior Director, Government Relations, or Katie Grady, ACR Government Affairs Director.
The 21st Century Cures Act (2016) addressed topics related to software oversight, data sharing, biomedical research funding and payment policy. Congress began to examine Cures Act-related gaps and opportunities in 2019, an effort that was coined “Cures 2.0,” and ultimately helped establish the Advanced Research Projects Agency for Health (ARPA-H).
The latest white paper, “A Roadmap for 21st Century Cures Next Steps for the Cures 2.0 Act and the 21st Century Cures Initiative,” suggests focus areas for future Cures-related legislative activities, including changes to Medicare payment policy and local coverage determination processes, U.S. Preventive Services Task Force processes, clinical trials access, health information exchange, software/medical device oversight, and more.
ACR members with questions about Cures 2.0 can contact Michael Peters, ACR Senior Director, Government Relations, or Katie Grady, ACR Government Affairs Director.
Related ACR News
CMS Announces Prior Authorization Test Model
WiSer is a six-year program that will begin in six states on January 1, 2026. It will introduce prior authorization using AI technology for a select number of services, including some IR procedures.
Read moreSupreme Court Upholds Preventive Services Coverage
ACR commends the Supreme Court’s ruling affirming the constitutionality of the structure and appointment process of the U.S. Preventive Services Task Force.
Read more